Loewenstein, Anat

Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective

Li, J.-P. O., Liu, H., Ting, D. S. J., Jeon, S., Chan, R. V. P., Kim, J. E., Sim, D. A., Thomas, P. B. M., Lin, H., Chen, Y., et al. (2021) · Progress in Retinal and Eye Research

Ophthalmology and Visual Health ResearchRetinal Imaging and Analysis

Cited by 626

2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations

Grzybowski, A., Told, R., Sacu, S., Bandello, F., Moisseiev, E., Loewenstein, A., Schmidt-Erfurth, U., & on behalf of the Euretina Board (2018) · Ophthalmologica

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 297

The suprachoroidal space: from potential space to a space with potential

Moisseiev, E., Loewenstein, A., & Yiu, G. (2016) · Clinical Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 76

Brolucizumab and immunogenicity

Sharma, A., Kumar, N., Parachuri, N., Sharma, R., Bandello, F., Kuppermann, B. D., & Loewenstein, A. (2020) · Eye

Retinal Diseases and TreatmentsBiosimilars and Bioanalytical Methods

Cited by 51

Drug delivery to the posterior segment of the eye

Moisseiev, E., & Loewenstein, A. (2017) · Developments in Ophthalmology

Advanced Drug Delivery SystemsRetinal Diseases and Treatments

Cited by 46

Abicipar pegol—a novel anti-VEGF therapy with a long duration of action

Moisseiev, E., & Loewenstein, A. (2020) · Eye

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 36

Noninfectious Inflammatory Response following Intravitreal Bevacizumab Injections: Description of a Cluster of Cases in Two Centers and a Review of the Literature

Trivizki, O., Schwartz, S., Negri, N., Loewenstein, A., Rabina, G., & Shulman, S. (2018) · Ophthalmologica

Ocular Diseases and Behçet’s SyndromeOcular Infections and Treatments

Cited by 11